Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Volodymyr Novakivskyy"'
Autor:
Volodymyr Novakivskyy, Roman Shurduk, Inna Grin, Taisiia Tkachenko, Nataliia Pavlenko, Anastasiia Hrynevych, Jeffrey L Hymes, Franklin W Maddux, Stefano Stuard
Publikováno v:
Clinical Kidney Journal. 16:676-683
In January 2021, there were 9648 patients in Ukraine on kidney replacement therapy, including 8717 on extracorporeal therapies and 931 on peritoneal dialysis. On 24 February 2022, foreign troops entered the territory of Ukraine. Before the war, the F
Autor:
Natalia Stepanova, Mykola Kolesnyk, Zain Mithani, Baneen Alkofair, Rebecca Lauren Shakour, Anna Petrova, Volodymyr Novakivskyy, Jeffrey L. Hymes, Szymon Brzosko, Jeff Giullian, Zelde Espinel, James M. Shultz
Publikováno v:
Clin J Am Soc Nephrol
Publikováno v:
Український Журнал Нефрології та Діалізу, Iss 3(59), Pp 18-24 (2018)
Наукові дані щодо дозозалежного впливу тривалого активатора рецепторів еритропоетину (ТАРЕ) на показники оксидативного стресу та пере
Publikováno v:
Nephrology Dialysis Transplantation. 34
Publikováno v:
Український Журнал Нефрології та Діалізу, Iss 1(61), Pp 29-38 (2019)
We hypothesized that the use of antihypertensive medications in patients treated by hemodialysis (HD) may interfere with the activity of erythropoietin and leads to an increase in the dose of erythropoiesis stimulating agents (ESAs). The aim of our s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e0d56097b268f6b19e9a7a01fba5416
https://zenodo.org/record/3342018
https://zenodo.org/record/3342018
Publikováno v:
Український Журнал Нефрології та Діалізу, Iss 3(47), Pp 57-64 (2015)
The object was to study the effect of oxidative factors and methods of renal replacement therapy (RRT) on indices of oxidative stress (OS) and resistance cells in blood in patients with chronic kidney disease stage V(CKD VD) and anemic syndrome. Mate
Publikováno v:
Nephrology Dialysis Transplantation. 33:i559-i559
Publikováno v:
Nephrology Dialysis Transplantation. 33:i466-i466
Publikováno v:
Web of Science
INTRODUCTION AND AIMS:L-type dihydropyridine calcium channel blockers (L-TCCs) are commonly used in hemodialysis (HD) patients as “cardioprotective” antihypertensive medications. L-TCCs have often been compared to other antihypertensive agents in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a241239f357bd29ef143313ea98747df
https://publons.com/wos-op/publon/10895178/
https://publons.com/wos-op/publon/10895178/